About This Talk
Bruno joined Novartis Global Drug Development in 2019 and leads Data and Digital. He is focused on fully integrating data science, A.I. and digital technology into the drug portfolio and development processes.
A digital and technology leader, Bruno has more than 30 years of experience driving digital and technology-led innovation and new business model creation in the pharmaceutical, consumer health, and service industries. Prior to joining Novartis, Bruno led the development of a portfolio of digital health companies in the US. Before, he worked at Takeda Pharmaceuticals in Japan where he became the first Chief Digital Officer in the pharmaceutical industry.
In addition, Bruno serves as a Board Advisor for Koneksa Health (The digital biomarker company), Cara Care (Personalized gastrointestinal care), Seqster (The Operating System for Digital Health) and the Intermediate Capital Group (Private Equity European leader). He previously served as Chairman and Board Member of a few Digital Health startups. Bruno is a regular contributor to events & media and a Forbes Technology Council member.
Bruno has a Master of Science in Industrial Organization and a Master of Science in Business Systems from the University of Lyon. He also has a Master of Engineering in Enterprise Systems from the Arts & Métiers in Paris. In 2017, he was nominated a Top 40 healthcare transformer.